Your browser doesn't support javascript.
loading
Antibiotic-mediated gut microbiome perturbation accelerates development of type 1 diabetes in mice.
Livanos, Alexandra E; Greiner, Thomas U; Vangay, Pajau; Pathmasiri, Wimal; Stewart, Delisha; McRitchie, Susan; Li, Huilin; Chung, Jennifer; Sohn, Jiho; Kim, Sara; Gao, Zhan; Barber, Cecily; Kim, Joanne; Ng, Sandy; Rogers, Arlin B; Sumner, Susan; Zhang, Xue-Song; Cadwell, Ken; Knights, Dan; Alekseyenko, Alexander; Bäckhed, Fredrik; Blaser, Martin J.
Afiliación
  • Livanos AE; Departments of Medicine and Microbiology, Human Microbiome Program, New York University Langone Medical Center, Medical Service, New York, New York 10016, USA.
  • Greiner TU; Department of Molecular and Clinical Medicine, University of Gothenburg, 40530 Gothenburg, Sweden.
  • Vangay P; Biomedical Informatics and Computational Biology Program, University of Minnesota, Minneapolis, Minneapolis 55455, USA.
  • Pathmasiri W; Systems and Translational Sciences, RTI International, Research Triangle Park, North Carolina 27709, USA.
  • Stewart D; Systems and Translational Sciences, RTI International, Research Triangle Park, North Carolina 27709, USA.
  • McRitchie S; Systems and Translational Sciences, RTI International, Research Triangle Park, North Carolina 27709, USA.
  • Li H; Departments of Population Health, New York University Langone Medical Center, New York, New York 10016, USA.
  • Chung J; Departments of Medicine and Microbiology, Human Microbiome Program, New York University Langone Medical Center, Medical Service, New York, New York 10016, USA.
  • Sohn J; Departments of Medicine and Microbiology, Human Microbiome Program, New York University Langone Medical Center, Medical Service, New York, New York 10016, USA.
  • Kim S; Departments of Medicine and Microbiology, Human Microbiome Program, New York University Langone Medical Center, Medical Service, New York, New York 10016, USA.
  • Gao Z; Departments of Medicine and Microbiology, Human Microbiome Program, New York University Langone Medical Center, Medical Service, New York, New York 10016, USA.
  • Barber C; Departments of Medicine and Microbiology, Human Microbiome Program, New York University Langone Medical Center, Medical Service, New York, New York 10016, USA.
  • Kim J; Departments of Medicine and Microbiology, Human Microbiome Program, New York University Langone Medical Center, Medical Service, New York, New York 10016, USA.
  • Ng S; Departments of Medicine and Microbiology, Human Microbiome Program, New York University Langone Medical Center, Medical Service, New York, New York 10016, USA.
  • Rogers AB; Department of Biomedical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, Massachusetts 01536, USA.
  • Sumner S; Systems and Translational Sciences, RTI International, Research Triangle Park, North Carolina 27709, USA.
  • Zhang XS; Departments of Medicine and Microbiology, Human Microbiome Program, New York University Langone Medical Center, Medical Service, New York, New York 10016, USA.
  • Cadwell K; Department of Microbiology, New York University Langone Medical Center, New York, New York 10016, USA.
  • Knights D; Skirball Institute, New York University Langone Medical Center, New York, New York 10016, USA.
  • Alekseyenko A; Computer Science and Engineering, University of Minnesota, Minneapolis, Minneapolis 55455, USA.
  • Bäckhed F; Biotechnology Institute, University of Minnesota, Saint Paul, Minneapolis 55108, USA.
  • Blaser MJ; Departments of Medicine and Microbiology, Human Microbiome Program, New York University Langone Medical Center, Medical Service, New York, New York 10016, USA.
Nat Microbiol ; 1(11): 16140, 2016 Aug 22.
Article en En | MEDLINE | ID: mdl-27782139

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Penicilina V / Diabetes Mellitus Tipo 1 / Microbioma Gastrointestinal / Antibacterianos Límite: Animals Idioma: En Revista: Nat Microbiol Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Penicilina V / Diabetes Mellitus Tipo 1 / Microbioma Gastrointestinal / Antibacterianos Límite: Animals Idioma: En Revista: Nat Microbiol Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos